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INTRODUCTION
Increasing medical expenses have become a signifi-
cant problem in various countries1）. The estimated ex-
penditure for national medical care in Japan during 
2008 was 36 .8％ for inpatients and 53 .2％ for outpa-
tients （including pharmacy） and these costs are ex-
pected to continuously increase2）. Outpatient care that 
includes medical consultations and drug costs comprise 
over half of the national medical care expenditure in 
Japan. The Organization for Economic Co-operation 
and Development （OECD） data for 2009 show that 
the average number of medical consultations per indi-
vidual per year in Japan is 13.4, compared with 6.5 in 
other OECD countries. The Japanese average is the 
highest among OECD countries and over three-fold 
that in the USA1）. Over half of the national medical 
care expenditure on outpatients was for individuals 
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SUMMARY
Background：Data from the Organization for Economic Co-operation and Development （OECD） show 
that Japan among OECD countries has the highest average number of medical consultations. The present 
study estimates the burden of cardiovascular risk factors on the frequency of medical consultations among 
Japanese National Health Insurance beneficiaries.
Methods and Results：We analyzed data from 3,648 individuals aged 40-74 years who had participated 
in health checks that were linked to monthly medical expenditure records with billing dates. The odds ra-
tios （ORs） of factors for the prevalence of frequent medical consultations were calculated using a multivari-
able logistic regression analysis. The population attributable fractions （PAF） of each factor for such preva-
lence defined as over 12 medical consultations per year were also calculated as days. The odds ratios of 
hypertension, dyslipidemia and diabetes were 2.5 （95％ confidence interval （CI） ：2.1, 2.9）, 2.3 （95％ CI：
1.9, 2.7） and 2.3 （95％ CI：1.7, 3.1）, respectively and the PAF were 29.0％, 20.5％, and 5.8％, respectively. 
The odds ratios of hypertension in men and women were 2.6 （95％ CI：2.2, 3.3） and 2.6 （95％ CI：2.1, 3.2）, 
respectively with PAF of 33.4％ and 27.4％, respectively.
Conclusions：Hypertension imposes the largest burden on the frequency of medical consultations among 
examined factors. Therefore, preventing incident hypertension might be the most important factor influenc-
ing medical expenditures.
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METHODS
Data collection
Data were collected from Japanese beneficiaries of 
the National Health Insurance （NHI） system in Shimo-
tsuke, Japan. The study area comprised 59,392 （29,433 
men, 29 ,959 women） residents and 26 ,466 （13 ,344 
men, 13,122 women） of them were aged 40-74 years 
in 2009. A total of 15,568 （26.1％） residents were NHI 
beneficiaries, of whom 9,803 （37.0％） were aged 40-74 
years. We enrolled 3 ,648 （13 .8％） （1,544 men and 
2,104 women） beneficiaries aged 40-74 years who had 
undergone health checks between April 2009 and 
March 2010 . The essential examination items mea-
sured during the health checkups included blood pres-
sure, serum triglycerides, high-density lipoprotein cho-
lesterol, fasting blood sugar or hemoglobin A1c, and 
abdominal circumference as an index of visceral fat 
obesity. The Tochigi Public Health Service Association 
and several medical institutions conducted health 
checks. Accuracy control at all of these institutions 
was under external investigations by appropriate 
agencies such as the Japan Medical Association and 
each institution also implemented regular internal in-
vestigations. The Tochigi Public Health Service Asso-
ciation examined 1,619 persons and 2,029 were exam-
ined at 26 medical institutions. The beneficiaries were 
linked to health check data by personal code, gender, 
birthday and address code.
Health check data and medical expenditure records 
that included the number of medical consultations as 
outpatients were collected from the Shimotsuke City 
Government. The data were depersonalized to ensure 
anonymity.
The institutional review board of Dokkyo Medical 
University School of Medicine approved the study pro-
tocol.
Frequency of medical consultations
The outpatients were linked to monthly medical ex-
penditure records with billing dates between May 
2009 and April 2010. The medical consultation dates 
on most of the linked medical expenditure records 
were between April 2009 and March 2010 （Japanese 
fiscal year）. Medical expenditure records included the 
number of outpatient medical consultations expressed 
aged over 65 years 3）. Elderly outpatients generally 
have chronic diseases that require frequent treatment 
such as hypertension, renal failure and cardiac isch-
emia, metabolic syndrome, chronic obstructive pulmo-
nary and liver diseases4）. The number of patients with 
lifestyle-related diseases has increased in Japan；thus, 
measures have been implemented to reduce the inci-
dence of such diseases. One measure that has been im-
plemented since 2008 is that all insured individuals 
aged 40-74 years are obligated to undergo annual 
health checks （and if necessary, health guidance） to 
focus on preventing lifestyle-related diseases and met-
abolic syndrome5）. These diseases require continuous 
medication and can lead to even more serious condi-
tions that impose further medical expense. Evidence to 
support a decision to prioritize certain controllable risk 
factors is required since health care resources are lim-
ited.
Many studies have addressed the burden of risk fac-
tors such as hypertension6〜9）, obesity10 ,11）, diabetes 
mellitus12〜14）, cardiovascular disease15,16）, serum alanine 
aminotransferase levels 17）, chronic kidney disease18）, 
proteinuria19）, alcohol consumption20） and smoking 
habit21,22） on medical care expenditure for various cate-
gories of inpatients, outpatients and pharmacies. The 
proportion of medical care expenditure across these 
three categories （inpatients, outpatients and pharma-
cies） is highest for diseases of the circulatory system 
such as hypertension, cardiac ischemia and cerebro-
vascular diseases23）. The highest burden on medical 
care expenditures of outpatients is unknown because 
most surveys used medical expenditure records that 
depended on one main diagnosis among several. Selec-
tion and concentration are needed because resources 
for disease prevention such as budgets, public health 
nurses and physicians are limited. However, modifiable 
cardiovascular risk factors among outpatients who fre-
quently consult physicians have not been comprehen-
sively analyzed. Thus, the most critical factor for con-
trolling the incremental burden of outpatients has 
remained unknown. Specific health checks focus on 
preventable hypertension, diabetes and dyslipidemia 
that are risk factors for cardiovascular disease. Thus, 
the present study examines the burden of each factor 
on the frequency of outpatient consultations among 
Japanese National Health Insurance beneficiaries.
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quency of medical consultations were calculated using 
a multivariable logistic regression analysis. The popu-
lation attributable fractions （PAF） of each risk factor 
for the frequency of medical consultations were calcu-
lated using the formula：
PAF＝1−∑
p
OR
where p is the proportion of exposure, and OR is the 
odds ratio.
The PAF is most commonly defined as a proportion-
al reduction in average disease risk over a specified in-
terval that would be achieved by eliminating the expo-
sure of interest from the population while the 
distributions of other risk factors in the population re-
main constant. This can also be interpreted as diseases 
over a specific period that would be prevented by 
eliminating the exposure, assuming that exposure is 
causal31）.
All data were analyzed using the statistical package 
SAS 9.1.
RESULTS
Table 1 shows the characteristics of patients who 
completed health checks and had medical expenditures 
records. The mean age of the patients was 64.6 （men, 
65 .0；women, 64 .3） years. Mean values for BMI, ab-
dominal circumference, systolic blood pressure, diastol-
ic blood pressure, triglycerides, fasting blood glucose 
and HbA1c were statistically higher in men than in 
women （all p＜0 .05）, whereas those for HDL- and 
as days. We defined≥12 medical outpatient consulta-
tions between May 2009 and April 2010 as frequent. 
We therefore presumed that outpatients consult physi-
cians at least once a month.
Statistical analysis
Hypertension was defined as systolic blood pressur
≥1 4 0 mmHg and/or diastolic blood pressure≥9 0 
mmHg according to the World Health Organization 
（WHO） classification24,25） or use of anti-hypertensive 
medication. Dyslipidemia was defined as serum triglyc-
erides≥150 mg/dL and/or high-density lipoprotein 
cholesterol＜40 mg/dL according to the Third Report 
of the National Cholesterol Education Program 
（NCEP） Expert panel on Detection, Evaluation, and 
Treatment of High Blood Cholesterol in Adults （ATP 
III）26） or the use of anti-dyslipidemic medication. Dia-
betes was defined according to the WHO classification 
as fasting plasma glucose≥126 mg/dL27） and/or hemo-
globin Alc≥6.1％ according to the Japan Diabetes Soci-
ety （JDS）28,29） or the use of anti-diabetic medication. 
Values for HbA1c （％） were estimated as National Gly-
cohemoglobin Standardization Program （NGSP） equiv-
alent values （％） and were calculated using the formu-
la HbA1c （％）＝HbA1c （JDS）（％）＋0.4％, considering 
the relational expression of HbA1c （JDS）（％） deter-
mined according to previous Japanese standard sub-
stance and measurement methods and HbA 1 c
（NGSP） 30）.
The odds ratios （OR） of each risk factor for the fre-
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Table 1　Characteristics of study subjects
Total Men Women
p-value
n Ave.±SD n Ave.±SD n Ave.±SD
Age（years） 3648 64.6±7.9 1544 65.0±7.9 2104 64.3±7.8 0.0095
BMI（kg/m2） 3648 23.3±3.3 1544 23.7±2.9 2104 23.0±3.5 ＜.0001
Abdominal Circumference（cm） 3647 83.6±8.9 1544 85.1±7.9 2103 82.5±9.4 ＜.0001
Systolic Blood Pressure（mmHg） 3648 129.8±16.4 1544 131.5±15.7 2104 128.6±16.8 ＜.0001
Diastolic Blood Presure（mmHg） 3648 76.3±10.5 1544 78.1±10.2 2104 75.0±10.5 ＜.0001
HDL Cholesterol（mg/dL） 3647 63.5±17.0 1544 57.8±15.4 2103 67.7±16.8 ＜.0001
Triglycerides（mg/dL） 3648 113.8±68.6 1544 127.1±83.3 2104 104.0±53.4 ＜.0001
LDL Cholesterol（mg/dL） 3648 124.8±28.9 1544 120.4±28.3 2104 128.0±28.8 ＜.0001
Fasting Blood Glucose（mg/dL） 3311 99.6±18.9 1386 103.2±22.2 1925 96.9±16.3 ＜.0001
HbA1c（％） 338 5.8±0.8 159 5.9±0.9 179 5.7±0.6 0.0265
p-value：tested by t-test
HbA1c（％）：the data is presented as National Glycohemoglobin Standardization Program（NGSP）
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cal consultations within the Japanese NHI system. 
Therefore, incident hypertension could be the most 
critical risk factor affecting medical economics in Ja-
pan.
Many studies have revealed the burden of risk fac-
tors such as hypertension6〜9,32,33）, obesity10,34）, diabetes 
mellitus12〜14）, cardiovascular disease15） on medical care 
expenditure for one or more categories of inpatients, 
outpatients and pharmacy worldwide. However, few 
studies have examined the frequency of medical con-
sultations in terms of cardiovascular disease （CVD） 
risk factors.
A Japanese survey of patients estimated that 471 , 
147 and 93 outpatients/100,000 individuals/day were 
associated with hypertensive disease, diabetes mellitus 
and hyperlipidemia, respectively 23）. Another study of 
medical expenditure taken from NHI records found 
that 11,869 and 3,393 outpatients/100,000 beneficia-
ries/day were associated with hypertension and diabe-
tes mellitus, respectively 35）. These findings revealed 
that the estimated rate of outpatients with hyperten-
sion was higher than that of other risk factors. Howev-
er, the patients in these studies were surveyed at a 
fixed point, and the study using medical expenditure 
records depended on one main diagnosis among sever-
LDL-cholesterol were statistically higher in women 
than in men （p＜0.05）.
Table 2 shows the multivariable OR and PAF of risk 
factors for the frequency of medical consultations. The 
multivariable OR of hypertension was highest among 
men and overall. The ORs for hypertension, dyslipi-
demia, diabetes and the frequency of medical consulta-
tions associated with each factor among men were 2.6 
（95％ CI：2.2, 3.3）, 1.9 （95％ CI：1.5, 2.5）, 2.6 （95％ 
CI：1.8 , 3 .8）, respectively. These values for women 
were 2.6 （95％ CI：2.1, 3.2）, 2.7 （95％ CI：2.1, 3.4） 
and 2.5 （95％ CI：1.4, 4.3）, respectively. The OR for 
hypertension was 2.5 （95％ CI：2.1, 2.9） for the men 
and women combined. On the other hand, the PAF of 
hypertension was highest in men and in women, as 
well as in the total. The PAF of hypertension for fre-
quent medical consultations was 33 .4％, 27 .4％ and 
29.0％ in men, women and in the total of both, respec-
tively.
DISCUSSION
To the best of our knowledge, this is the first study 
to show that among the three measured factors （hy-
pertension, dyslipidemia and diabetes） hypertension 
imposed the highest burden on the frequency of medi-
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Table 2　 Odds ratios and PAF for prevalence of outpatient consultations （≥12 days/year） according to hypertension, 
dyslipidemia, and diabetes＊
Factor
proportion of 
exposure（％）
odds ratio adjusted  
for age （95％ CI）†
PAF（％）‡
odds ratio adjusted  
for all （95％ CI）†
PAF（％）‡
Total
hypertension 48.8 3.03　（　2.51　−　3.66　） 32.67 2.47　（　2.12　−　2.88　） 29.04
dyslipidemia 37.0 2.82　（　2.30　−　3.46　） 23.88 2.25　（　1.91　−　2.65　） 20.54
diabetes 10.2 4.31　（　2.73　−　6.79　） 7.83 2.29　（　1.68　−　3.13　） 5.75
Men
hypertension 54.3 3.18　（　2.44　−　4.15　） 37.19 2.60　（　2.17　−　3.27　） 33.4
1dyslipidemia 38.5 2.19　（　1.66　−　2.89　） 20.90 1.93　（　1.51　−　2.45　） 8.49
diabetes 14.3 5.35　（　2.99　−　9.60　） 11.64 2.57　（　1.75　−　3.77　） 8.74
Women
hypertension 44.7 3.18　（　2.42　−　4.18　） 30.64 2.58　（　2.08　−　3.20　） 27.40
dyslipidemia 35.9 4.09　（　2.96　−　5.66　） 27.15 2.67　（　2.12　−　3.37　） 22.49
diabetes 7.2 3.62　（　1.75　−　7.52　） 5.20 2.49　（　1.44　−　4.32　） 4.30
＊ hypertension：SBP≥140 mmHg or DBP≥90 mmHg or medicated, dyslipidemia：150 mg/dl≥Triglycerides or HDL 
Cholesterol＜40 mg/dl or medicated, diabetes：Fasting Blood Glucose ≥126 mg/dl or A1c≥6.5 or medicated （National 
Glycohemoglobin Standardization Program）.
†Calculated by logistic regression analysis all：age, hypertension, dyslipidemia, diabetes.
‡PAF：Population attributable fraction.
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hypertension and diabetes or more factors would be 
higher44,45）.
The present study has several limitations. Firstly, 
possible selection bias might not have been ruled out 
due to the low rate of participation in health checks 
（37.0％）. Thus, the generalizability of the data might 
be uncertain. However, the Japanese National Health 
and Nutrition Survey 200846） found that the propor-
tions of men, women and the total of both aged 40-74 
years with hypertension （systolic and/or diastolic 
blood pressure of≥140 and≥90 mmHg, respectively, 
or prescribed with anti-hypertensive medication） 
were 58.4％, 44.4％ and 50.2％ （present study, 54.3％, 
44 .7％ and 48 .8％）, respectively. The proportions of 
obese （abdominal circumference for men and women,
≥85 and≥90 cm, respectively） men, women and both 
were 56.3％, 20.7％ and 36.6％ （present study, 49.8％, 
20 .3％ and 32 .8％）, respectively. The selection bias 
might be small because the proportions of hyperten-
sion and obesity in the present study were similar to 
those of the Japanese National Health and Nutrition 
Survey. Secondly, PAF is affected by prevalence of 
diseases in the population. The individuals in the pres-
ent study who attended health checks might differ 
from the general population. For example, those who 
undergo health checks might be healthier than those 
who do not. Thus, PAF might be underestimated due 
to an underestimated population of exposure values 
and ORs. However, this suggests that the PAF for hy-
pertension in the present study are lower than that for 
the total number of beneficiaries. Thirdly, the age dis-
tribution of the individuals in the present study dif-
fered from that of the entire Japanese population. 
Among people aged 40-74 years, the proportion of 
those aged over 65 years in the present study was 
57.6％, which is higher than the 26.4％ in the general 
Japanese population. The ratio of elderly people who 
are NHI beneficiaries is generally higher because of an 
eligibility requirement for NHI （that is, farmers, self-
employed, retirees and their dependents）. Further-
more, the incidence of diseases increases due to aging 
among elderly people. However, PAFs were adjusted 
for age and all factors （hypertension, dyslipidemia, dia-
betes）；thus, it might not be significantly influenced 
by the age distribution of the studied individuals. 
Fourthly, this study focused on total dates of medical 
al diagnoses. Therefore, the results of these studies 
might not show the actual frequency of medical con-
sultations for specific diseases. Our study of the fre-
quency of medical consultations intended to clarify 
which diseases were treated most frequently and we 
identified hypertension as the most common condition 
among outpatients. A 10-year follow-up study of 4,191 
Japanese NHI beneficiaries aged 40-69 years found 
that outpatient medical expenditures for hypertension-
related conditions are increasing regardless of the 
grade of hypertension （pre-hypertension, Stages 1 and 
2）7）. Therefore, hypertension should be prevented 
rather than controlled to reduce hypertension- related 
medical expenditures.
The American Heart Association estimated that the 
prevalence of hypertension in the USA is 73 （males, 
34；females, 39） million, meaning that almost one third 
of all adults≥20 years of age is hypertensive. The 
prevalence of physician-diagnosed diabetes mellitus is 
15.1 （males, 7.6；females, 7.5） million, 7.3％ in adults 
and 10.1％ in adults if undiagnosed diabetes is includ-
ed3 6）. The Behavioral Risk Factor Surveillance 
（BRFFS） of non-institutionalized adults in the USA 
found that the estimated prevalences of hypertension 
and diabetes are 28 . 3％ and 8 . 1％, respectively, in 
those≥18 years of age37）. The American Heart Associ-
ation projected that the population with hypertension 
will increase from 33.9％ to 37 .3％ and that the esti-
mated medical cost of hypertension would triple be-
tween 2010 and 203036）. Although these values were 
not compared with other factors, hypertension is also 
the major factor associated with medical consultations 
and medications for outpatients in other countries38〜40）. 
Thus, hypertension should be prevented worldwide.
Hypertension is recognized as the most expensive 
factor associated with CVD, because it leads to compli-
cations such as heart failure, coronary heart disease 
and stroke15,41,42）. Another cohort study in Japan found 
that obese participants （BMI≥25） had a higher preva-
lence of hypertension, hypercholesterolemia and diabe-
tes mellitus and that the prevalence of hypertension 
among those who were obese was substantially high10）. 
In fact, BMI is associated with physician visits42,43）. Ac-
cordingly, some obese patients would undergo medical 
consultations due to hypertension, diabetes or dyslipi-
demia. The medical costs to treat patients with both 
39（3） （2012） 177
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Eisei no Doko 2011/2012 （Trend for National Health 
and Hygiene, Japan）. Tokyo：Health and Welfare Sta-
tistics Association：2012.
 3） Ikegami N, Yoo BK, Hashimoto H, et al：Japanese 
universal health coverage：evolution, achievements, 
and challenges, The Lancet 378：1106–1115, 2011.
 4） Ministry of Health, Labour and Welfare. Handbook of 
Health and Welfare Statistics 2010［http://www.mhlw.
go.jp/english/database/db-hh/5-1 .html］ （accessed 
March 25 2012）.
 5） Kohro T, Furui Y, Mitsutake N, et al：The Japanese 
National Health Screening and intervention program 
aimed at preventing worsening of the metabolic syn-
drome. Int Heart J 49：193-203, 2008.
 6） Balu S, Thomas J：3rd. Incremental expenditure of 
treating hypertension in the United States. Am J Hy-
pertens 19：810-816, 2006.
 7） Nakamura K, Okamura T, Kanda H, et al：Impact of 
hypertension on medical economics：a 10-year fol-
low-up study of national health insurance in Shiga, 
Japan. Hypertens Res 28：859-864, 2005.
 8） Chen Y, Matsumura Y, Nakagawa K, et al：Analysis 
of yearly variations in drug expenditure for one pa-
tient using data warehouse in a hospital. J Med Syst 
31：17-24, 2007.
 9） Wang YR, Alexander GC, Stafford RS：Outpatient 
hypertension treatment, treatment intensification, and 
control in Western Europe and the United States. 
Arch Intern Med 167：141-147, 2007.
 10） Nakamura K, Okamura T, Kanda H, et al：Medical 
costs of obese Japanese：a 10-year follow-up study 
of National Health Insurance in Shiga, Japan. Eur J 
Public Health 17：424-429, 2007.
 11） Thompson D, Brown JB, Nichols GA, et al：Body 
mass index and future healthcare costs：a retrospec-
tive cohort study. Obes Res 9：210-218, 2001.
 12） Balu S：Incremental treatment expenditure of diabe-
tes in the United States. Manag Care Interface 20：
20-27, 2007.
 13） Nakamura K, Okamura T, Kanda H, et al：Medical 
expenditure for diabetic patients：a 10-year follow-
up study of National Health Insurance in Shiga, Japan. 
Public Health 122：1226-1228, 2008.
 14） Chatterjee S, Riewpaiboon A, Piyauthakit P, et al：
Cost of diabetes and its complications in Thailand：a 
complete picture of economic burden. Health Soc Care 
consultations；therefore, consultations for other diseas-
es might have been included. However, we consider 
that most medical consultations were for chronic dis-
eases due to the focus on frequent medical consulta-
tions （≥12 days/year） in this study. Moreover, the 
PAF of hypertension was calculated using a multivari-
able regression analysis adjusted for other factors 
（dyslipidemia, diabetes） as complications of hyperten-
sion. For the reasons stated above, we believe that the 
high frequency of medical consultation for hyperten-
sion was mainly caused by treatment for hypertension.
The incidence of hypertension increases with age. 
Therefore, the number of hypertensive patients is like-
ly to increase as the Japanese population rapidly ages. 
This study shows that the prevention of incident hy-
pertension can control excessive increases in medical 
expenses. Diet （such as low-salt） and aerobic and oth-
er types of exercise to prevent hypertension also si-
multaneously help to prevent other life-style related 
diseases such as diabetes and dyslipidemia. According-
ly, measures aimed at preventing hypertension will be-
come even more important in the future.
CONCLUSION
Medical consultations due to hypertension impose a 
larger burden on the Japanese National Health Insur-
ance system than the risk factors of dyslipidemia and 
diabetes. Therefore, prevention of incident hyperten-
sion could be the most critical factor involved in the 
control of escalating medical expenditures.
Acknowledgments　We thank the National Health 
Insurance in Shimotsuke for providing access to their 
database.
Competing interests
None.
Funding
None.
REFERENCES
 1） OECD Health Data 2011［http://stats.oecd.org/Index.
aspx?DatasetCode=CSP2011］ （accessed March 25 
2012）.
 2） Health and Welfare Statistic Association：Kokumin 
178 DJMS
Burden of outpatient risk factors on NHI in Japan
2572, 2003.
 25） Organization WH：Prevention of cardiovascular dis-
ease：guidelines for assessment and management of 
cardiovascular risk. Geneva WHO press：40-41, 2007.
 26） Expert Panel on Detection, Evaluation, and Treat-
ment of High Blood Cholesterol in Adults. Executive 
summary of the third report of the National Choles-
terol Education Program （NCEP） Expert Panel on 
detection, evaluation and treatment of high blood cho-
lesterol in adults （Adult Treatment Pane Ⅲ）. JAMA 
285：2486-2497, 2001.
 27） Organization WH：Definition and diagnosis of diabe-
tes mellitus and intermediate hyperglycaemia：report 
of a WHO/IDF consultation. Geneva：WHO Docu-
ment Production Services：1-3, 2006.
 28） Organization WH：Use of Glycated haemoglobin 
（HbA1c） in the diagnosis of diabetes mellitus. Gene-
va：WHO press：2, 2011.
 29） Tominaga M, Makino H, Yoshino G, et al：Japanese 
standard reference material for JDS Lot 2 haemoglo-
bin A1c. I：Comparison of Japan Diabetes Society-as-
signed values to those obtained by the Japanese and 
USA domestic standardization programmes and by 
the International Federation of Clinical Chemistry ref-
erence laboratories. Ann Clin Biochem 42：41-46 , 
2005.
 30） The Committee of Japan Diabetes Society on the di-
agnostic criteria of diabetes mellitus：Report of the 
Committee on the classification and diagnostic criteria 
of diabetes mellitus. J Diabetes invest 1：212-228 , 
2010.
 31） Rockhill B, Newman B, Weinberg C：Use and misuse 
of population attributable fractions. Am J Public 
Health 88：15-19, 1998.
 32） Sasai H, Sairenchi T, Irie F, et al：Long-term expo-
sure to elevated blood pressure and mortality from 
cardiovascular disease in a Japanese population：the 
Ibaraki Prefectural Health Study. Hypertens Res 34：
139–144, 2011.
 33） Sairenchi T, Irie F, Izumi Y, et al：Age-Stratified 
Analysis of the Impact of Hypertension on National 
Health Insurance Medical Expenditures in Ibaraki, Ja-
pan. J Epidemiol 20：192-196, 2010.
 34） Finkelstein EA, Brown DS, Trogdon JG, et al：Age-
specific impact of obesity on prevalence and costs of 
diabetes and dyslipidemia. Value Health 10：45-51 , 
Community 19：289-298, 2011.
 15） Heidenreich PA, Trogdon JG, Khavjou OA, et al：
Forecasting the future of cardiovascular disease in 
the United States：A policy statement from the 
American Heart Association. Circulation 123：933-
944, 2011.
 16） Okamura T, Nakamura K, Kanda H, et al：Effect of 
combined cardiovascular risk factors on individual 
and population medical expenditures：a 10-year co-
hort study of national health insurance in a Japanese 
population. Circ J 71：807-813, 2007.
 17） Nakamura K, Okamura T, Kanda H, et al：The value 
of combining serum alanine aminotransferase levels 
and body mass index to predict mortality and medical 
costs：a 10-year follow-up study of National Health 
Insurance in Shiga, Japan. J Epidemiol 16：15-20 , 
2006.
 18） Higashiyama A, Okamura T, Watanabe M, et al：Ef-
fect of chronic kidney disease on individual and popu-
lation medical expenditures in the Japanese popula-
tion. Hypertens Res 32：450-454, 2009.
 19） Nakamura K, Okamura T, Kanda H, et al：Medical 
costs of individuals with proteinuria：A 10-year fol-
low-up study of National Health Insurance in Shiga, 
Japan. Public Health 121：174-176, 2007.
 20） Kanda H, Nakamura K, Hayakawa T, et al：The influ-
ence of alcohol drinking on medical care expenditures 
among National Health Insurance beneficiaries. Nihon 
Arukoru Yakubutsu Igakkai Zasshi 40：171-180 , 
2005.
 21） Izumi Y, Tsuji I, Ohkubo T, et al：Impact of smoking 
habit on medical care use and its costs：a prospective 
observation of National Health Insurance beneficiaries 
in Japan. Int J Epidemiol 30：616-621, 2001.
 22） Nakamura K, Okamura T, Hayakawa T, et al：Medi-
cal expenditures of men with hypertension and/or a 
smoking habit：a 10-year follow-up study of National 
Health Insurance in Shiga, Japan. Hypertens Res 33：
802-807, 2010.
 23） Ministry of Health, Labour and Welfare：Patient Sur-
vey 2008 ［http://www.e-stat.go.jp/SG1/estat/List.
do?lid=000001060228h］ （accessed March 25 2012）.
 24） Chobanian AV, Bakris GL, Black HR, et al：The Sev-
enth Report of the Joint National Committee on Pre-
vention, Detection, Evaluation, and Treatment of High 
Blood Pressure：the JNC7 report. JAMA 289：2560-
39（3） （2012） 179
Hiromi Taneichi
2007.
 35） Kitazawa T, Matsumoto K. Sakamaki H, et al：An 
ecological study of the association between disease 
specific medical costs and socioeconomic factors. Jour-
nal of Japan Society for Health Care Management 8：
512-520, 2008.
 36） Rosamond W, Fleqal K, Furie K, et al：Heart Disease 
and Stroke Statistics-2008 Update：a report from the 
American Heart Association Statistics Committee and 
Stroke Statistics Subcommittee. Circulation 117：25-
146, 2008.
 37） Chowdhury P, Balluz L, Town M, et al：Surveillance 
of certain health behaviors and conditions among 
states and selected local areas-Behavioral Risk Factor 
Surveillance System, United States, 2007 . MMWR 
Surveill Summ 59：1-220, 2010.
 38） Capilheira MF, da Silva Dos Santos I.：Individual fac-
tors associated with medical consultation by adults. 
Rev Saude Publica 40：436-443, 2006.
 39） Lonati C, Morganti A, Comarella L, et al：Prevalence 
of type 2 diabetes among patients with hypertension 
under the care of 30 Italian clinics of hypertension：
results of the （Iper） tensione and （dia） bete study. J 
Hypertens 26：1801-1808, 2008.
 40） Egan BM, Zhao Y, Axon RN, et al：Uncontrolled and 
apparent treatment resistant hypertension in the 
United States, 1988 to 2008. Circulation 124：1046-
1058, 2011.
 41） Balu S.：Estimated annual direct expenditures in the 
United States as a result of inappropriate hyperten-
sion treatment according to national treatment guide-
lines. Clin Ther 31：1581-1594, 2009.
 42） Frost GS, Lyons GF, Counterweight Project Team：
Obesity Impacts on General Practice Appointments. 
Obes Res 13：1442-1449, 2005.
 43） Kuriyama S, Tsuji I, Ohkubo T, et al：Medical care 
expenditure associated with body mass index in Ja-
pan：the Ohsaki Study. Int J Obes Relat Metab Dis-
ord 26：1069-1074, 2002.
 44） Nakamura K, Okamura T, Kanda H, et al：Medical 
costs of patients with hypertension and/or diabetes：
A 10-year follow-up study of National Health Insur-
ance in Shiga, Japan. J Hypertens 24：2305-2309 , 
2006.
 45） Sakamaki H, Kitazawa T, Muto T：Study of clarifying 
incidence of lifestyle-related diseases and related 
complications and its medical expenses using govern-
ment-managed health insurance data. Nihon Eisei-
gaku Zasshi 63：651-661, 2008.
 46） Ministry of Health, Labour and Welfare：National 
Health and Nutrition Survey 2008［http://www.mhlw.
go.jp/houdou/2008/04/h0430-2 .html］ （accessed 
March 25 2012）.
180 DJMS
